Environmental Factors and IBD: Elusive or non-existent?

von Kappelman, Michael D.
Veröffentlicht in Inflamm Bowel Dis (2013)

Does Inflammatory Bowel Disease Develop in Infants?

von Kappelman, Michael D., Grand, Richard J.
Veröffentlicht 2008

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases

von Brenner, Erica J., Kappelman, Michael D.
Veröffentlicht in Clin Gastroenterol Hepatol (2021)

Quality of Health Care in the United States: Implications for Pediatric Inflammatory Bowel Disease

von Boyle, Brendan M., Palmer, Lena, Kappelman, Michael D.
Veröffentlicht in J Pediatr Gastroenterol Nutr (2009)

Non-Melanoma Skin Cancer in Inflammatory Bowel Disease: A Review

von Long, Millie D., Kappelman, Michael D., Pipkin, Clare A.
Veröffentlicht 2010

Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US

von Egberg, Matthew D, Galanko, Joseph A, Kappelman, Michael D
Veröffentlicht in Inflamm Bowel Dis (2020)

A causal association between Accutane and IBD has yet to be established

von Crockett, Seth D., Gulati, Ajay, Sandler, Robert S., Kappelman, Michael D.
Veröffentlicht 2009

Increased Risk of Herpes Zoster among 108,604 Patients with Inflammatory Bowel Disease

von Long, Millie D., Martin, Christopher, Sandler, Robert S., Kappelman, Michael D.
Veröffentlicht 2012

Topiramate use does not reduce flares of inflammatory bowel disease

von Crockett, Seth D., Schectman, Robin, Stürmer, Til, Kappelman, Michael D.
Veröffentlicht 2014

Health care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States

von Jensen, Elizabeth T., Kappelman, Michael D., Martin, Christopher F., Dellon, Evan S.
Veröffentlicht in Am J Gastroenterol (2014)

Increased Risk of Pneumonia among Patients with Inflammatory Bowel Disease

von Long, Millie D., Martin, Christopher, Sandler, Robert S., Kappelman, Michael D.
Veröffentlicht in Am J Gastroenterol (2013)

Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database

von Jensen, Elizabeth T., Martin, Christopher F., Kappelman, Michael D., Dellon, Evan S.
Veröffentlicht in J Pediatr Gastroenterol Nutr (2016)

Suboptimal Rates of Cervical Testing Among Women with Inflammatory Bowel Disease

von Long, Millie D, Porter, Carol Q, Sandler, Robert S, Kappelman, Michael D
Veröffentlicht 2008

The Risk of Diagnosed Fractures in Children with Inflammatory Bowel Diseases

von Kappelman, Michael D., Galanko, Joseph A., Porter, Carol Q., Sandler, Robert S.
Veröffentlicht 2010

Surveillance for Hepatocellular Carcinoma in a Medicaid Cirrhotic Population

von Palmer, Lena B., Kappelman, Michael D., Sandler, Robert S., Hayashi, Paul H.
Veröffentlicht 2013

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

von Ungaro, Ryan C., Kappelman, Michael D., Rubin, David T., Colombel, Jean-Frederic
Veröffentlicht in Gastroenterology (2021)

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population

von Kappelman, Michael D., Moore, Kristen R., Allen, Jeffery K., Cook, Suzanne F.
Veröffentlicht 2012

Racial Disparities in Readmission, Complications and Procedures in Children with Crohn’s Disease

von Dotson, Jennifer L., Kappelman, Michael D., Chisolm, Deena J., Crandall, Wallace V.
Veröffentlicht in Inflamm Bowel Dis (2015)

Use of methotrexate in the treatment of inflammatory bowel diseases (IBD)

von Herfarth, Hans H., Kappelman, Michael D, Long, Millie D, Isaacs, Kim L
Veröffentlicht in Inflamm Bowel Dis (2016)

Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease

von Egberg, Matthew D, Galanko, Joseph A, Barnes, Edward L, Kappelman, Michael D
Veröffentlicht in Inflamm Bowel Dis (2019)